Cullinan Therapeutics, Inc.
NASDAQ:CGEM · NASDAQ Global Select
+$0.62 today
Vol 3.11M · Avg 0.99M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+98.28%
Period High
$16.44
Period Low
$5.75
Latest
$15.03
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
RAPT Therapeutics, Inc.
RAPT
$959.26M
Omeros Corporation
NASDAQ:OMER
$732.44M
Enhabit, Inc.
EHAB
$706.91M
CeriBell, Inc.
NASDAQ:CBLL
$665.88M
Varex Imaging Corporation
NASDAQ:VREX
$438.29M
Standard BioTools Inc.
NASDAQ:LAB
$312.26M
Bicycle Therapeutics plc
NASDAQ:BCYC
$277.58M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$270.51M
So-Young International Inc.
NASDAQ:SY
$196.90M
ADC Therapeutics S.A.
NYSE:ADCT
$138.00M
What is the latest CGEM filing?
The latest filing shown is 8-K dated Jun 16, 2026.
How many recent filings does CGEM have?
Intrinsic Alpha currently shows 20 recent filings for CGEM.
Explore More
Continue the stock analysis
Jump to another research area for this company.